Addiction and substance abuse in anesthesiology

Anesthesiology

Volumn 109, Issue 5, 2008, Pages 905-917

  Bryson, Ethan O ^a   Silverstein, Jeffrey H ^b  

^a MOUNT SINAI HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBUSE; DISULFIRAM; FENTANYL; KETAMINE; LIDOCAINE; NALTREXONE; NITROUS OXIDE; PROPOFOL; SUFENTANIL; THIOPENTAL; UNCLASSIFIED DRUG; NARCOTIC ANALGESIC AGENT;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ABSTINENCE; ALCOHOLISM; ANESTHESIST; ANXIETY; ARTHRALGIA; CHILL; CLINICAL FEATURE; CLINICAL PRACTICE; COMORBIDITY; CONSTIPATION; DEPRESSION; DETOXIFICATION; DIARRHEA; DIZZINESS; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG COST; DRUG EFFECT; DRUG ERUPTION; GENERAL ANESTHESIA; HEADACHE; HUMAN; IMPOTENCE; IRRITABILITY; MEDICAL EDUCATION; MENTAL DISEASE; MYALGIA; NAUSEA; NERVOUSNESS; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SIDE EFFECT; SLEEP DISORDER; SUBSTANCE ABUSE; URINALYSIS; VOMITING; ADDICTION; ANESTHESIOLOGY; MALPRACTICE; PSYCHOLOGICAL ASPECT;

ANALGESICS, OPIOID; ANESTHESIOLOGY; BEHAVIOR, ADDICTIVE; HUMANS; MENTAL DISORDERS; PHYSICIAN IMPAIRMENT; PROFESSIONAL IMPAIRMENT; SUBSTANCE-RELATED DISORDERS;

EID: 56149102813     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181895bc1     Document Type: Review

References (92)

1. Silverstein JH, Silva DA, Iberti TJ: Opioid addiction in anesthesiology. ANESTHESIOLOGY 1993; 79:354-75
2. Collins GB, McAllister MS, Jensen M, Gooden TA: Chemical dependency treatment outcomes of residents in anesthesiology: Results of a survey. Anesth Analg 2005; 101:1457-62
3. Kintz P, Villain M, Dumestre V, Cirimele V: Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic Sci Int 2005; 153:81-4
4. Wischmeyer PE, Johnson BR, Wilson JE, Dingmann C, Bachman HM, Roller E, Tran ZV, Henthorn TK: A survey of propofol abuse in academic anesthesia programs. Anesth Analg 2007; 105:1066-71
5. Hughes PH, Baldwin DC Jr, Sheehan DV, Conard S, Storr CL: Resident physician substance use, by specialty. Am J Psychiatry 1992; 149:1348-54
6. Gold MS, Byars JA, Frost-Pineda K: Occupational exposure and addictions for physicians: Case studies and theoretical implications. Psychiatr Clin North Am 2004; 27:745-53
7. Brewster JM: Prevalence of alcohol and other drug problems among physicians. JAMA 1986; 255:1913-20
8. Krizek TJ: The impaired surgical resident. Surg Clin North Am 2004; 84: 1587-604
9. Talbott GD, Gallegos KV, Wilson PO, PorterTL: The Medical Association of Georgia's Impaired Physicians Program review of the first 1,000 physicians: Analysis of specialty. JAMA 1987; 257:2927-30
10. Alexander BH, Checkoway H, Nagahama SI, Domino KB: Cause-specific mortality risks of anesthesiologists. ANESTHESIOLOGY 2000; 93:922-30
11. Booth JV, Grossman D, Moore J, Lineberger C, Reynolds JD, Reves JG, Sheffield D: Substance abuse among physicians: A survey of academic anesthesiology programs. Anesth Analg 2002; 95:1024-30
12. Report of the Board of Trustees. JAMA 1956; 162:750
13. Lettieri DJ: Drug abuse: A review of explanations and models of explanation, Alcohol and Substance Abuse in Adolescence. Edited by Stimmel B. New York, Haworth, 1985, pp 9-40
14. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC, Lester HA: Nicotine activation of α4* recep- tors: Sufficient for reward, tolerance, and sensitization. Science 2004; 306: 1029-32
15. Mohn AR, Yao WD, Caron MG: Genetic and genomic approaches to reward and addiction. Neuropharmacology 2004; 47:101-10
16. Lesch KP: Alcohol dependence and gene x environment interaction in emotion regulation: Is serotonin the link? EurJ Pharmacol 2005; 526:113-24
17. Hiroi N, Agatsuma S: Genetic susceptibility to substance dependence. Mol Psychiatry 2005; 10:336-44
18. Kreek MJ, Nielsen DA, LaForge KS: Genes associated with addiction: Alcoholism, opiate, and cocaine addiction. NeuromolecularMed 2004; 5:85-108
19. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, Fuxe K, Changeux JP: Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 1998; 391:173-7
20. WangJC, Hinrichs AL, Stock H, BuddeJ, Allen R, Bertelsen S, KwonJM, Wu W, Dick DM, Rice J, Jones K, Nurnberger JI Jr, Tischfield J, Porjesz B, Edenberg HS, Hesselbrock V, Crowe R, Schuckit M, Begleiter H, Reich T, Goate AM, Bierut LJ: Evidence of common and specific genetic effects: Association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet 2004; 13:1903-11
21. Luo X, Kranzler HR, Zuo L, Wang S, Blumberg HP, Gelernter J: CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: Results from an extended case-control structured association study. Hum Mol Genet 2005; 14:2421-34
22. Nace EP, Davis CW, Gaspari JP: Axis II comorbidity in substance abusers. Am J Psychiatry 1991; 148:118-20
23. Udel MM: Chemical abuse/dependence: Physicians' occupational hazard. J Med Assoc Ga 1984; 73:775-8
24. Markou A, Kosten TR, Koob GF: Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology 1998; 18:135-74
25. Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, Suzuki K, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Mori N: Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry 2003; 160:1699-701
26. Malison RT, Best SE, Wallace EA, McCance E, Laruelle M, Zoghbi SS, Baldwin RM, SeibylJS, HofferPB, Price LH: Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts. Psychopharmacology 1995; 122:358-62
27. Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB, Gorey JG, Doty L, Geyer C, Lee KS, Coppola R, Weinberger DR, Linnoila M: Reduced central serotonin transporters in alcoholism. Am J Psychiatry 1998; 155:1544-9
28. Gold MS, Melker RJ, Dennis DM, Morey TE, Bajpai LK, Pomm R, Frost-Pineda K: Fentanyl abuse and dependence: Further evidence for second hand exposure hypothesis. J Addict Dis 2006; 25:15-21
29. White RK, Kitlowiski EJ: Physicians in recovery. Md Med J 1998; 37:183-9
30. Annitto WJ, Gold MS: Treating the "high and mighty" and the "mighty high," Dual Diagnosis in Substance Abuse. Edited by Gold MS, Slaby AE. New York, Marcel Dekker, 1991, pp 289-95
31. Talbott GD: The impaired physician and intervention: A key to recovery. J Fla Med Assoc 1992; 69:793-7
32. Berry AJ, Arnold WP: Chemical Dependence in Anesthesiologists: What You Need to Know When You Need to Know It. Park Ridge, Illinois, American Society of Anesthesiologists Task Force on Chemical Dependence of the Committee on Occupational Health of Operating Room Personnel, 1998
33. Walzer RS: Impaired physicians: An overview and update of the legal issues. J Leg Med 1990; 11:131-98
34. Gualtieri AC, Cosentino JP, Becker JS: The California experience with the diversion program for impaired physicians. JAMA 1983; 249:226-9
35. Casper E, Dilts SL, Soter JJ: Establishment of the Colorado Physician Health Program with a legislative initiative. JAMA 1988; 260:671-3
36. Carden ET: Wither the impaired physician? The politics of impairment. Md Med J 1988; 37:206-10
37. Revocation of ABA certification. ABA News 2006; 19(1):4
38. Roback HB, Moore RF, Waterhouse GJ, Martin PR: Confidentiality dilemmas in group psychotherapy with substance-dependent physicians. Am J Psychiatry 1996; 153:1250-60
39. Gendel MH: Forensic and medical legal issues in addiction psychiatry. Psychiatr Clin North Am 2004; 27:611-26
40. Medical Practices Act, Colorado revised statutes, §§12-36-117, 118 (amended 1995)
41. Westreich LM: Addiction and the Americans with Disabilities act. J Am Acad Psychiatry Law 2002; 30:355-63
42. Metzner JL, Buck JB: Psychiatric disability determinations and personal injury litigation, Principles and Practice of Forensic Psychiatry. London, Arnold, 2003, pp 672-84
43. Traynor and McKelvey v Turnage, 485 US 539 (1988)
44. Menk EJ, Baumgarten RK, Kingsley CP: Success of reentry into anesthesiology training programs by residents with a history of substance abuse. JAMA 1990; 263:3060-2
45. Hankes L, Bissell L: Health Professionals, Substance Abuse: A Comprehensive Textbook. Edited by Lowinson JH, Ruiz P, Millman RB. Baltimore, Williams & Wilkins, 1992, pp 897-908
46. Pelton C, Ikeda RM: The California Physicians Diversion Program's experience with recovering anesthesiologists. J Psychoactive Drugs 1991; 23:427-31
47. Kirn TF: Advances in understanding of alcoholism initiate evolution in treatment programs. JAMA 1986; 256:1405-12
48. Rounsaville B, Karroll K: Individual psychotherapy for drug abusers, Substance Abuse: A Comprehensive Textbook. Edited by Lowinson JH, Ruiz P, Millman RB. Baltimore, Williams & Wilkins, 1992, pp 496-507
49. Fletcher CE, Ronis DE: Satisfaction of impaired health care professionals with mandatory treatment and monitoring. J Addict Dis 2005; 24:61-75
50. Canavan DI: Screening: Urine drug tests. Md Med J 1987; 36:229-33
51. Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF: Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res 2004; 28:1710-7
52. Haley TJ: Disulfiram (tetraethylthioperoxydicarbonic diamide): A reappraisal of its toxicity and therapeutic application. Drug Metab Rev 1979; 9:319-55
53. Galanter M, Talbott D, Gallegos K, Rubenstone E: Combined AA and professional care for addicted physicians. Am J Psychiatry 1990; 147:64-8
54. Galanter M, Casteneda R, Franco H: Group therapy and self-help groups, Clinical Textbook of Addictive Disorders. Edited by Frances RJ, Miller SI. New York, The Guilford Press, 1991, pp 431-51
55. Herrington RE, Benzer DG, Jacobson GR, Hawkins MK: Treating substance use disorders among physicians. JAMA 1982; 247:2253-7
56. Samkoff JS, Krebs JR: Families and physician impairment. Pa Med 1989; 92:38-9
57. O'Connor PG, Spickard A Jr: Physician impairment by substance abuse. Med Clin North Am 1997; 81:1037-52
58. Arico S, Zannero A, Galatola G: Family compliance to a treatment programme for alcoholics: A prospective study of prognostic factors. Alcohol 1994; 29:679-85
59. Singh J, Basu D: Ultra-rapid opioid detoxification: Current status and controversies. J Postgrad Med 2004; 50:227-32
60. van Dorp EL: Naloxone treatment in opioid addiction: The risks and benefits. Expert Opin Drug Saf 2007; 6:125-32
61. Collins ED, Kleber HD, Whittington RA, Heitler NE: Anesthesia-assisted versus buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: A randomized trial. JAMA 2005; 294:903-13
62. Gallegos KV, Browne CH, Veit FW, Talbott GD: Addiction in anesthesiologists: Drug access and patterns of substance abuse. QRB 1988; 14:116-22
63. Matsumura JS: Substance abuse and anesthesiology training. JAMA 1990; 264:2741-2
64. Talbott GD: Elements of the Impaired Physicians Program. J Med Assoc Ga 1984; 73:749-51
65. Collins GB, McAllister MS, Jensen M, Gooden TA: Chemical dependency treatment outcomes of residents in anesthesiology: Results of a survey. Anesth Analg 2005; 101:1457-62
66. Bryson EO, Levine A: One approach to the return to residency for anesthesia residents recovering from opioid addiction. J Clin Anesth 2008; 20:397-400
67. Domino KB, Hornbein TF, Polissar NF, Renner G, Johnson J, Alberti S, Hankes L: Risk factors for relapse in health care professionals with substance use disorders. JAMA 2005; 293:1453-60
68. Fletcher CE, Ronis DL: Satisfaction of impaired health care professionals with mandatory treatment and monitoring. J Addict Dis 2005; 24:61-75
69. Farley WJ, Talbott GD: ANESTHESIOLOGY and addiction (editorial). Anesth Analg 1983; 62:465-6
70. Kintz P, Villain M, Dumestre V, Cirimele V: Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic Sci Int 2005; 153:81-4
71. Adler GR, Potts FE III, Kirby RR: Narcotics control in anesthesia training. JAMA 1985; 253:3133-6
72. Moleski RJ, Easley S, Barash PG: Control and accountability of controlled substance administration in the operating room. Anesth Analg 1985; 64:989-95
73. Shafer AL, Lisman SR, Rosenberg MB: Development of a comprehensive operating room pharmacy. J Clin Anesth 1991; 3:156-66
74. Schmidt KA, Schlesinger MD: A reliable accounting system for controlled substances in the operating room. ANESTHESIOLOGY 1993; 78:184-90
75. Epstein RH, Gratch DM, Grunwald A: Development of a scheduled drug diversion surveillance system based on an analysis of atypical drug transactions. Anesth Analg 2007; 105:1053-60
76. Lutsky I, Hopwood M, Abram SE: Psychoactive substance use among American anesthesiologists: A 30-year retrospective study. Can J Anaesth 1993; 40:915-21
77. Substance-Abuse Testing Committee American Association for Clinical Chemistry: Critical issues in urinalysis of abuse substances: Report of the substance-abuse testing committee. Clin Chem 1988; 34:605-32
78. Chamberlain RT: Legal issues related to drug testing in the clinical laboratory. Clin Chem 1988; 34:633-6
79. Peat MA: Analytical and technical aspects of testing for drugs of abuse: Confirmatory procedures. Clin Chem 1988; 34:471-3
80. Blanke RV: Accuracy in Urinalysis, Urine Testing for Drugs of Abuse. NIDA Research Monograph No. 73. Edited by Hawks RL, Chaiang NC. Washington, DC, Government Printing Office, 1986, pp 43-53
81. Vereby K: Diagnostic laboratory: Screening for drug abuse, Substance Abuse: A Comprehensive Textbook. Edited by Lowinson JH, Ruiz P, Millman RB. Baltimore, Williams & Wilkins, 1992, pp 425-36
82. McCain DA, Hug CC Jr: Intravenous fentanyl kinetics. Clin Pharmacol Ther 1980; 28:106-14
83. Stoelting RK: Opioid agonists and antagonists, Pharmacology and Physiology in Anesthetic Practice. Philadelphia, JB Lippincott, 1987, pp 69-101
84. Henderson GL: Mechanism of drug incorporation into hair. Forensic Sci Int 1993; 63:19-29
85. Pragst F, Balikova MA: State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta 2006; 370:17-49
86. Romano N, Barbera G, Lombardo I: Hair testing for drugs of abuse: Evaluation of external cocaine contamination and risk of false positives. Forensic Sci Int 2001; 123:119-29
87. Romano N, Barbera G, Spadaro Valenti V: Determination of drugs of abuse in hair: Evaluation of external heroin contamination and risk of false positives. Forensic Sci Int 2003; 131:98-102
88. Clark HW: The role of physicians as medical review officers in workplace drug testing programs: In pursuit of the last nanogram. West J Med 1990; 152:514-24
89. Davis KH, Hawks RL, Blanke RV: Assessment of laboratory quality in urine drug testing: A proficiency testing pilot study. JAMA 1988; 260:1749-54
90. Struempler RE: Excretion of codeine and morphine following ingestion of poppy seeds. J Anal Toxicol 1987; 11:97-9
91. elSohly NH, elSohly MA, Stanford DF: Poppy seed ingestion and opiates urinalysis: A closer look. J Anal Toxicol 1990; 14:308-10
92. Fitzgerald RL, Ramos JM Jr, Bogema SC, Poklis A: Resolution of metham-phetamine stereoisomers in urine drug testing: Urinary excretion of R(-)-meth-amphetamine following use of nasal inhalers. J Anal Toxicol 1998; 12:255-9